Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Renovorx Inc
(NQ:
RNXT
)
1.010
+0.040 (+4.09%)
Streaming Delayed Price
Updated: 3:42 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Renovorx Inc
< Previous
1
2
3
4
5
6
7
Next >
Biopharma Company Issues New Patent Application Adding to Strong IP Portfolio of 9 Patents Issued and 9 Pending; Phase 3 Clinical Trials for Cancer Treatments in Collaboration with Imugene: RenovoRx (NASDAQ: RNXT) $RNXT
December 19, 2023
Via
Viz Release
Topics
Intellectual Property
Exposures
Intellectual Property
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 14, 2023
Via
Benzinga
RenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy Platform
December 13, 2023
From
RenovoRx, Inc.
Via
Business Wire
Recap: RenovoRx Q3 Earnings
November 14, 2023
Via
Benzinga
Biopharma Company Reaches Phase 3 Clinical Trials for Cancer Treatments; 9 Patents Issued; Collaboration with Imugene: RenovoRx (NASDAQ: RNXT)
December 12, 2023
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
RenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D.
November 16, 2023
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx Reports Third Quarter 2023 Financial Results and Operational Highlights
November 14, 2023
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx to Present at the ROTH MKM Healthcare Opportunities Conference on October 12, 2023
October 02, 2023
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx Reports Second Quarter 2023 Financial Results and Operational Highlights
August 17, 2023
From
RenovoRx, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
August 07, 2023
Via
Benzinga
RenovoRx to Present at the 43rd Annual Canaccord Genuity Growth Conference
July 31, 2023
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP™) Platform
July 20, 2023
Via
Get News
RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP™) Platform
July 20, 2023
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP™) Platform
July 20, 2023
--News Direct--
Via
News Direct
RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP™) Platform
July 20, 2023
Via
TheNewswire.com
RenovoRx, Inc. Stock Presents A Compelling Value Proposition After Reporting Positive Data From Its Phase III TIGeR-PaC Trial ($RNXT)
July 11, 2023
Via
AB Newswire
Topics
Death
Exposures
Death
RenovoRx, Inc. Stock Surges After Reporting Positive Data From Its Phase III TIGeR-PaC Trial ($RNXT)
July 05, 2023
Via
AB Newswire
Topics
Death
Exposures
Death
Why RenovoRx Stock Is Moving Today
June 29, 2023
RenovoRx, Inc. (NASDAQ: RNXT) shares are trading higher Thursday after the company released interim data on progression-free survival from Phase 3 open label TIGeR-PaC study of RenovoGem
Via
Benzinga
Microcap Biotech Stock RenovoRx is Shooting Higher Today: Here's Why
June 29, 2023
RenovoRx Inc (NASDAQ: RNXT) presented new data on progression-free survival (PFS) from the pivotal Phase 3 open-label TIGeR-PaC study of RenovoGem (intra-arterial administration of gemcitabine) in...
Via
Benzinga
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 29, 2023
Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash.
Via
Benzinga
RenovoRx encountering "a lot of enthusiasm" for innovative cancer platform
June 29, 2023
RenovoRx encountering "a lot of enthusiasm" for innovative cancer platform
Via
News Direct
Exposures
Product Safety
RenovoRx encountering "a lot of enthusiasm" for innovative cancer platform
June 29, 2023
RenovoRx Inc (NASDAQ:RNXT) CEO Shaun Bagai speaks to Thomas Warner during a visit to Europe to present at the ESMO World Congress on Gastrointestinal Cancer (ESMO GI) in Barcelona. Bagai gives an...
Via
TheNewswire.com
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 29, 2023
Via
Benzinga
RenovoRx Announces New Positive Interim Phase III Data Demonstrating RenovoGem™ Delays Cancer Progression by Eight Months in Locally Advanced Pancreatic Cancer
June 29, 2023
From
RenovoRx, Inc.
Via
Business Wire
Catalyst Watch: RenovoRx, Inc. Stock Jumps 14% Ahead of Thursday’s Phase III TIGeR-PaC Trial Update ($RNXT)
June 28, 2023
Via
AB Newswire
Topics
Death
Exposures
Death
Catalyst Watch: RenovoRx, Inc. Nears June 29th Data Release From Its Phase III TIGeR-PaC Trial Targeting Pancreatic Cancer ($RNXT)
June 26, 2023
Via
AB Newswire
Topics
Death
Exposures
Death
RenovoRx Appoints Margaret A. Tempero, M.D., to Scientific Advisory Board
June 20, 2023
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx Announces ROTH Capital Key Opinion Leader (KOL) Webcast on June 15
June 12, 2023
From
RenovoRx, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.